Study on interactions of endocrine disruptors with estrogen receptor-beta using fluorescence polarization.

In this study, we developed a rapid, simple and homogeneous human recombinant estrogen receptor-beta (hrER-beta) binding assay method using fluorescence polarization (FP) by applying a fluorescent ligand, fluorescein-labeled estradiol (F-E2). A Scatchard plot and a Hill plot analysis of the saturation binding assay using F-E2 and hrER-beta were studied. F-E2 showed a high affinity for hrER-beta, the dissociation constant was 5.53 nM, indicating that F-E2 is applicable to the hrER-beta binding assay. Competitive binding assays using F-E2, in which the FP values decreased upon the addition of compounds (competitors) were carried out to evaluate the binding characteristics of compounds with and without biological activities to hrER-beta. Twenty-one compounds, such as hormones, pharmaceuticals, industrial chemicals and phytoestrogens, were examined. The obtained sigmoidal inhibition curves were transformed into pseudo-Hill plots and the concentrations at 50% inhibition (IC50) and Hill coefficients, the degree of cooperativity in ER-ligand binding, were obtained from the regression equations. Antagonists exhibited larger Hill coefficients than agonists, showing the correlation between the Hill coefficients and the estrogenic/antiestrogenic activities.

[1]  N. Webster,et al.  The human estrogen receptor has two independent nonacidic transcriptional activation functions , 1989, Cell.

[2]  H. Gronemeyer,et al.  The nuclear receptor ligand-binding domain: structure and function. , 1998, Current opinion in cell biology.

[3]  Y. Ouchi,et al.  The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. , 1998, Biochemical and biophysical research communications.

[4]  M. Favata,et al.  A high-throughput fluorescent polarization assay for nuclear receptor binding utilizing crude receptor extract. , 2002, Analytical biochemistry.

[5]  J. Lakowicz,et al.  Use of a long-lifetime Re(I) complex in fluorescence polarization immunoassays of high-molecular-weight analytes. , 1998, Analytical chemistry.

[6]  B. Maliwal,et al.  Expanded dynamic range of free zinc ion determination by fluorescence anisotropy. , 1998, Analytical chemistry.

[7]  H Grøn,et al.  Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  K. S. Grant-Webster,et al.  Neurobehavioral effects of developmental methylmercury exposure. , 1995, Environmental health perspectives.

[9]  C D Humfrey,et al.  Reproductive health in humans and wildlife: are adverse trends associated with environmental chemical exposure? , 1997, The Science of the total environment.

[10]  A. Soto,et al.  Developmental effects of endocrine-disrupting chemicals in wildlife and humans. , 1993, Environmental health perspectives.

[11]  Daniel Metzger,et al.  Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.

[12]  C. Klinge,et al.  Estrogen receptor interaction with co-activators and co-repressors☆ , 2000, Steroids.

[13]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[14]  W. Checovich,et al.  Fluorescence polarization — a new tool for cell and molecular biology , 1995, Nature.

[15]  Takeshi Fukushima,et al.  Estrogen receptor binding assay method for endocrine disruptors using fluorescence polarization. , 2002, Analytical chemistry.

[16]  David A. Agard,et al.  The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.

[17]  P. Chambon,et al.  Functional domains of the human estrogen receptor , 1987, Cell.

[18]  A. Ellington,et al.  Adapting selected nucleic acid ligands (aptamers) to biosensors. , 1998, Analytical chemistry.

[19]  P. Chambon,et al.  Localisation of the oestradiol‐binding and putative DNA‐binding domains of the human oestrogen receptor. , 1986, The EMBO journal.

[20]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Taylor,et al.  Immunolocalisation of oestrogen receptor beta in human tissues. , 2000, Journal of molecular endocrinology.

[22]  S. Fawell,et al.  Identification of two transactivation domains in the mouse oestrogen receptor. , 1989, Nucleic acids research.

[23]  H. Pols,et al.  Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability. , 1999, Biochemical and biophysical research communications.

[24]  M Carlquist,et al.  Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist , 1999, The EMBO journal.